Free shipping on all orders over $ 500

Vixarelimab

Cat. No. M25025

All AbMole products are for research use only, cannot be used for human consumption.

Vixarelimab Structure
Synonym:

KPL-716

Size Price Availability Quantity
100ug USD 200  USD200 In stock
1mg USD 500  USD500 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Vixarelimab (KPL-716) is a human anti-oncostatin M (OSM) monoclonal antibody that binds to the beta chain of the OSM receptor and inhibits IL-31 and OSM signalling. Vixarelimab can be used in studies of inflammatory skin diseases such as atopic dermatitis and itchy nodular rash.

Chemical Information
CAS Number 2243320-83-2
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
References

[1] Howard Sofen, et al. EClinicalMedicine. Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study

Related IL Receptor/Related Products
IL-15-IN-1 

IL-15-IN-1 is a potent and selective Interleukin 15 (IL-15) inhibitor, inhibiting the proliferation of IL-15-dependent cells with an IC50 of 0.8 μM.

IL-17 modulator 3 

IL-17 modulator 3 is an IL-17 modulator.

IL-17 modulator 4 

IL-17 modulator 4 is a proagent of IL-17 modulator 1.

IL-17A modulator-3 

IL-17A modulator-3 is a IL-17A modulator.

IL-17 modulator 4 sulfate 

IL-17 modulator 4 sulfate is a proagent of IL-17 modulator 1.

  Catalog
Abmole Inhibitor Catalog




Keywords: Vixarelimab, KPL-716 supplier, IL Receptor/Related, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.